BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7905 related articles for article (PubMed ID: 24339410)

  • 1. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.
    Dou J; He X; Liu Y; Wang Y; Zhao F; Wang X; Chen D; Shi F; Wang J
    Cell Biol Int; 2014 Apr; 38(4):452-61. PubMed ID: 24339410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties.
    Zhao F; He X; Wang Y; Shi F; Wu D; Pan M; Li M; Wu S; Wang X; Dou J
    Biosci Trends; 2015 Oct; 9(5):325-34. PubMed ID: 26559025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
    Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
    J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zeb1 links epithelial-mesenchymal transition and cellular senescence.
    Liu Y; El-Naggar S; Darling DS; Higashi Y; Dean DC
    Development; 2008 Feb; 135(3):579-88. PubMed ID: 18192284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
    Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasis.
    Ran J; Lin DL; Wu RF; Chen QH; Huang HP; Qiu NX; Quan S
    Fertil Steril; 2015 Jun; 103(6):1606-14.e1-2. PubMed ID: 25963537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.
    Wang X; Zhao F; Shi F; He X; Pan M; Wu D; Li M; Zhang Y; Dou J
    Biomed Pharmacother; 2016 May; 80():136-144. PubMed ID: 27133050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
    Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
    Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study of the inhibitory effect and mechanism of B16F10-ESAT-6-gpi/IL-21 vaccine on the pulmonary metastasis in mouse models of melanoma].
    He X; Shi W; Zhao F; Wang J; Xu X; Tan Q; Sun Y; Chen D; Dou J
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):245-9. PubMed ID: 24989908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
    Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
    Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.
    Liu Y; Lu X; Huang L; Wang W; Jiang G; Dean KC; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Darling DS; Postigo A; Dean DC
    Nat Commun; 2014 Dec; 5():5660. PubMed ID: 25434817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
    Ren J; Chen Y; Song H; Chen L; Wang R
    J Cell Biochem; 2013 Jun; 114(6):1395-403. PubMed ID: 23255418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 396.